Botulinum toxin during CABG reduced atrial tachyarrhythmia recurrence

26.10.20151681
Patients injected with botulinum toxin while undergoing CABG were significantly less likely to experience recurrent atrial fibrillation or atrial tachycardia than patients who received placebo, with no additional adverse effects, according to recent study results.

Novel therapies target hyperkalemia, improve use of RAAS inhibitors

23.10.20151791
Hyperkalemia occurs frequently in patients with chronic kidney disease and HF, and is also a common complication of renin-angiotensin-aldosterone inhibitor use.

Трансляции заседаний общества ССХ и лекций для ординаторов и аспирантов 1 года на сайте racvs.ru 23 октября

22.10.20151908
На сайте Ассоциации сердечно-сосудистых хирургов России (racvs.ru) продолжаются онлайн трансляции лекций для ординаторов и аспирантов первого года обучения.

Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database

22.10.20151653
Numerous studies have been conducted in many countries to identify the factors associated with readmission of patients with heart failure (HF).

Beta-blockers may increase perioperative MACE, mortality risk in uncomplicated hypertension

21.10.20151698
Perioperative treatment with a beta-blocker may be linked to elevated risk for major adverse CV events and all-cause mortality in patients with uncomplicated hypertension undergoing noncardiac surgery, according to recent findings.

Young women with acute MI less likely to receive, adhere to pharmacotherapy

20.10.20151617
Young women with acute MI are less likely than young men to use secondary prevention CV medications, according to study findings published in Circulation: Cardiovascular Quality and Outcomes.

Downgrading risk to minimize statin use in an era of increased statin eligibility

19.10.20151886
The 2013 American College of Cardiology/American Heart Association guidelines introduced the 10-year atherosclerotic CVD risk estimator to guide clinician–patient risk discussions about statin therapy.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.